Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Osteoporotic Fractures
- FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA
- Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
- Iron Supplementation for Geriatric Hip Fractures
- Romosozumab Use to Build Skeletal Integrity
- Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture
- Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
- Breast Cancer Women on Aromatase Inhibitors Treatment
- Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
- PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
- Preventing Osteoporosis Using Denosumab
- Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece
- Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)
- Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty
- Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
- BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.
- Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture